Background: Baroreflex sensitivity assessments have been considered to be important to evaluate cardiac autonomic neuropathy. The phenylephrine method, Valsalva maneuver or sequence method at rest caused several problems. We evaluated the usefulness of the sequence method during deep respiration. Method: Baroreflex sensitivity was evaluated in 20 normal volunteers and 50 patients with Parkinson’s disease. R–R intervals and systolic blood pressures were obtained by electrocardiogram and tonometry using a continuous blood pressure monitoring system. The sequence method is an evaluation of baroreflex sensitivity using sequences of 3 or more consecutive beats for 4 min. Baroreflex sensitivity was also assessed by the Valsalva maneuver at 5 beats before the peak systolic blood pressure of phase IV. The slope of the linear interrelationship between systolic blood pressure and the following R–R interval, i.e. baroreflex sensitivity (ms/mm Hg), was calculated with a correlation coefficient greater than 0.8. Result: The mean value of baroreflex sensitivity obtained by the Valsalva maneuver was 7.91 in normal volunteers and 5.35 in patients with Parkinson’s disease; the one obtained by the sequence method at rest was 9.10 in normal volunteers and 8.42 in patients with Parkinson’s disease, and the one obtained by the sequence method during deep respiration was 10.23 in normal volunteers and 6.73 in patients with Parkinson’s disease. In some cases with Parkinson’s disease, baroreflex sensitivities could not be found, whereas in all patients with Parkinson’s disease, the sequence method during deep respiration could be used for evaluations. Significant correlations were found among the baroreflex sensitivities obtained by the Valsalva maneuver, and the sequence method at rest or during deep respiration in normal volunteers and patients with Parkinson’s disease. Conclusions: The baroreflex sensitivity obtained by the sequence method during deep respiration could be investigated noninvasively in all cases with PD, being thus a useful method for clinical evaluation of baroreflex sensitivity.

1.
Bristow A, Honour AJ, Pickering GW, Sleight P, Smith HS: Diminished baroreflex sensitivity in high blood pressure. Circulation 1969;39:48–54.
2.
Gribbin B, Pickering TG, Sleight P, Peto R: Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971;29:424–431.
3.
Coleman TG: Arterial baroreflex control of heart rate in the conscious rat. Am J Physiol 1980;238:H515–H520.
4.
Kirchheim HR: Systemic arterial baroreceptor reflexes. Physiol Rev 1976;56:100–176.
5.
Kalbfleisch JH, Stowe DF, Smith JJ: Evaluation of the heart rate response to the Valsalva maneuver. Am Heart J 1978;95:707–715.
6.
Palmero HA, Caeiro TF, Iosa DJ, Bas J: Baroreceptor reflex sensitivity index derived from phase 4 of the Valsalva maneuver. Hypertension 1981;3:134–137.
7.
Kardos A, Rudas L, Simon J, Gingl Z, Csanady M: Effect of postural changes on arterial baroreflex sensitivity assessed by the spontaneous sequence method and Valsalva manoeuvre in healthy subjects. Clin Auton Res 1997;7:143–148.
8.
Kautzner J, Hartikainen JEK, Camm AJ, Malik M: Arterial baroreflex sensitivity assessed from phase IV of the Valsalva maneuver. Am J Cardiol 1996;78:575–579.
9.
Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL: Spectral analysis of blood pressure and heart rate in conscious rats: Effects of autonomic blockers. J Auton Nerv Syst 1990;30:91–100.
10.
Ursino M, Magosso E: Role of short-term cardiovascular regulation in heart period variability: A modeling study. Am J Physiol Heart Circ Physiol 2003;284:H1479–H1493.
11.
Hayano J, Taylor JA, Yamada A, Mukai S, Hori R, Asakawa T, Yokoyama K, Watanabe Y, Takata K, Fujinami T: Continuous assessment of hemodynamic control by complex demodulation of cardiovascular variability. Am J Physiol 1993;264:H1229–H1238.
12.
Bertinieri G, di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G: A new approach to analysis of the arterial baroreflex. J Hypertens Suppl 1985;3(suppl 3):S79–S81.
13.
Watkins LL, Fainman C, Dimsdale J, Ziegler MG: Assessment of baroreflex control from beat-to-beat blood pressure and heart rate changes: A validation study. Psychophysiology 1995;32:411–414.
14.
Weston PJ, Panerai RB, McCullough A, McNally PG, James MA, Potter JF, Thurston H, Swales JD: Assessment of baroreceptor-cardiac reflex sensitivity using time domain analysis in patients with IDDM and the relation to left ventricular mass index. Diabetologia 1996;39:1385–1391.
15.
Oka H, Mochio S, Sato H, Inoue K: Comparison of baroreceptor reflex sensitivity between sequence method and Valsalva’s maneuver. Auton Nerv Syst (Tokyo) 1999;36:36–41.
16.
Diehl RR, Linden D, Berilit P: Determinants of heart rate variability during deep breathing: Basic findings and clinical applications. Clin Auton Res 1997;7:131–135.
17.
Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–184.
18.
Sato T, Nishinaga M, Kawamoto A, Ozawa T, Takatsuji H: Accuracy of a continuous blood pressure monitor based on arterial tonometory. Hypertension 1993;21:866–874.
19.
Freeman R: Noninvasive evaluation of heart rate variability; in Low PA, et al (eds): Clinical Autonomic Disorders, ed 2. Philadelphia, Lippincott-Raven, 1997, pp 297–307.
20.
Levy MN, DeGeest H, Zieske H: Effects of respiratory center activity on the heart. Circ Res 1966;18:67–78.
21.
Koizumi K, Ishikawa T, Nishino H, Brooks CM: Cardiac and autonomic system reactions to stretch of the atria. Brain Res 1975;87:247–261.
22.
Bainbridge FA: The influence of venous filling upon the rate of the heart. J Physiol 1915;50:65–84.
23.
Taha BH, Simon PM, Dempsey JA, Skatrud JB, Iber C: Respiratory sinus arrhythmia in humans: An obligatory role for vagal feedback from the lungs. J Appl Physiol 1995;78:638–645.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.